ALECTOR, INC.
Last · —$1.88+0.01 (+0.53%)live · yahoo · 2h ago
Vol 1.27M ≈ 2.42M
MA10MA20MA50
Market cap$209.92M—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
Issuer
Legal nameALECTOR, INC.
HQUnited States (US)
ListingUS ALEC
ISINUS0144421072
SectorHealthcare
IndustryBiotechnology & Medical Research
SIC2836
CurrencyUSD
Entity registrysec:0001653087
CIK0001653087
Websitewww.alector.com
Employees103
AddressAlector, Inc. 131 Oyster Point Boulevard 94080-2029, South San Francisco +415 231 5660
| Revenue | $13.9M |
|---|---|
| Operating income | $-49.3M |
| Net income | $-45.9M |
| Free cash flow | $-84.2M |
| Operating margin | -355.7% |
| Net margin | -331.2% |
| Period | TTM 2026-06-30 |
Loading chart…
OpenFilings analyst
Our analyst
10-K · 2026-02-25
From latest 10-K · 2026-02-25
- Sbc Revenue High
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Conversion Weak
- Cash Runway Low
- Accumulated Deficit High
- Rd Intensity High
Red flags
- Sbc Revenue High — SBC/Revenue 126.7%
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -679.2%
- Cash Conversion Weak — Cash conversion (CFO/Rev) -874.5%
- Cash Runway Low — Cash runway ~0.4 years
- Accumulated Deficit High — Accumulated deficit / equity 3172%
- Rd Intensity High — R&D/Revenue 584.8%
Upcoming earnings
THU.5NOV
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.22
Est. revenue
2.4M
Press & signals
- Satelight
Alector Enters Global License Agreement with Genentech for Brain
Documents
FormReporting forFiledFlags
Showing 5 of 116 filings